Building Pharmaceutical Supply-Chain Resilience

Building Pharmaceutical Supply-Chain Resilien...

Up next

Introducing: Our Town

Our Town from Bloomberg’s Big Take podcast follows residents of Gainesboro, Tennessee, after a group of far-right Christians moves in with plans for a radical social experiment.Listen to Episode 1 on the Big Take.See omnystudio.com/listener for privacy information. 

Bloomberg Businessweek Weekend - August 7th, 2026

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."Hosted by Carol Massar and Tim StenovecHear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/ ...  Show more

Recommended Episodes

The search for a remedy
The Story

As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ...  Show more

Unlocking Growth: How Digital Innovation is Transforming Commercial Manufacturing
The Lens: Life Sciences Reinvention in Focus

In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares h ...  Show more

301: Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise
The Readout Loud

Oruka Therapeutics CEO Lawrence Klein joins us to discuss how his company raised its first round of financing before competing with major players in the inflammation space. We also discuss the latest news in the life sciences, including the end of the Amylyx ALS saga, another use ...  Show more

How CytoReason is Bridging the Data Insight Gap to Accelerate Healthcare Breakthroughs - Ep. 276
NVIDIA AI Podcast

Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion, talks about the next frontier in healthcare: disease modeling. Shai shares how CytoReason bridges the gap between exploding biological data and actionable insight, powering smarter, faster ...  Show more